| 발표일자: |
2013년 4월 20일(토) ~ 21일(일) |
| 발표시간: |
|
| 발표번호: |
P(e-poster)-151 |
| 발표장소: |
|
|
|
| A case of retinal fold induced by Topiramate |
| Department of Ophthalmology, Kim’s Eye Hospital, Myung-Gok Eye Research Institute, College of Medicine, Konyang University, Seoul, Korea |
| Seong Hun Jeong, M.D, Myung Jin Cho, M.D, Seung-Hee Baek, MD, PhD, Yong Ran Kim, MD, Ungsoo Samuel Kim, MD |
|
목적 : To summarize and discuss the case of retinal fold induced by Topiramate with spectral optical coherence tomography (OCT) findings
방법 : A 36-year-old woman complained about visual disturbance seeing things at far distance four days ago. She insisted that her best corrected visual acuity was 1.0 in both eyes before the onset of visual disturbance. Her uncorrected visual acuity was 0.06 in both eyes due to myopia (-3.25 diopter).
결과 : On the fundus examination, retinal fold was found in both eyes. Spectral domain OCT revealed that retinal fold had an internal limiting membrane condensation. She took Phendimetrazine and Topiramate daily to treat obesity. Three days after discontinuation, her visual acuity has recovered by 1.0 in both eyes. Myopia has been resolved so as the retinal fold.
결론 : Topiramate is a sulfamate-substituted monosaccharide and the sulfamate induced myopia is predominantly due to ciliochoroidal effusion. Recently, retinal fold induced by Topiramate was noticed in the internal limiting membrane. Consequently, spectral domain OCT are considered to be well suited for studying retinal fold induced by Topiramate
|
| |